Around 80–90% population of CD41+ platelets was seen in gated events (platelets) from healthy controls as well as in HCC patients while striking difference with marked decrease in case of cirrhosis was observed where it was as low as 61.9–66%. This evidence concerns the gene ITGA2B and hepatocellular carcinoma.